Skip to main content
SpringerLink
Log in

Can VEGF-D and VEGFR-3 be used as biomarkers for therapeutic decisions in patients with gastric cancer?

  • Practice Point
  • Published:

From Nature Clinical Practice Oncology

View current issue Sign up to alerts

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Roukos DH and Kappas AM (2005) Perspectives in the treatment of gastric cancer. Nat Clin Pract Oncol 2: 98–107

    Article  Google Scholar 

  2. Simon R (2005) Roadmap for developing and validating therapeutically relevant genomic classifiers. J Clin Oncol 23: 7332–7341

    Article  CAS  Google Scholar 

  3. Ransohoff DF (2005) Bias as a threat to the validity of cancer molecular-marker research. Nat Rev Cancer 5: 142–149

    Article  CAS  Google Scholar 

  4. Kattan MW et al. (2005) Postoperative nomogram for disease-specific survival after an R0 resection for gastric carcinoma. J Clin Oncol 21: 3647–3650

    Article  Google Scholar 

  5. Chen CN et al. (2005) Gene expression profile predicts patient survival of gastric cancer after surgical resection. J Clin Oncol 23: 7286–7295

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Petra Roberts, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. assistant professor and Director of the Surgical Oncology and Genomics Research Unit,

    Dimitrios H Roukos, Theodore Liakakos, Gabriel Karatzas & Angelos M Kappas

  2. professor and Head of Department at the Department of Surgery, Ioannina University School of Medicine, Greece

    Dimitrios H Roukos, Theodore Liakakos, Gabriel Karatzas & Angelos M Kappas

  3. professor of Surgery,

    Dimitrios H Roukos, Theodore Liakakos, Gabriel Karatzas & Angelos M Kappas

  4. professor and Head of the Department of Surgery, at the Attiko University Hospital, University of Athens, Greece

    Dimitrios H Roukos, Theodore Liakakos, Gabriel Karatzas & Angelos M Kappas

Authors
  1. Dimitrios H Roukos
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Theodore Liakakos
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Gabriel Karatzas
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Angelos M Kappas
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Dimitrios H Roukos.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Roukos, D., Liakakos, T., Karatzas, G. et al. Can VEGF-D and VEGFR-3 be used as biomarkers for therapeutic decisions in patients with gastric cancer?. Nat Rev Clin Oncol 3, 418–419 (2006). https://doi.org/10.1038/ncponc0540

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncponc0540

  • Springer Nature Limited

This article is cited by

Search

Navigation